| ■ 영문 제목 : Global Bone Grafts and Substitutes Market 2023-2027 | |
![]() | ■ 상품코드 : IRTNTR73350-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 2월 최신판(2025년 또는 2026년)은 문의주세요. ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (24시간 이내) ■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD2,500 ⇒환산₩3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,600,000 | 견적의뢰/주문/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| Technavio사는 세계의 골이식편 및 골대체물 시장 규모가 2022년부터 2027년 사이에 1,450.51 백만 달러에 달하며, 예측기간 중에 연평균 8.71% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 골이식편 및 골대체물 시장에 대해 조사 및 분석하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 제품별 (이종 이식, 동종 이식, 인공 골이식, DBM) 분석, 용도별 (척추 고정술, 외상, 두개골 안면, 관절 재건, 기타) 분석, 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 기타 지역, 미국, 독일, 영국, 중국, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corp., Johnson and Johnson, Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc. 와 같은 기업 정보를 포함하고 있습니다. ・개요 ・시장 현황 ・시장 규모 예측 ・과거 시장 규모 ・Five Force 분석 ・세계의 골이식편 및 골대체물 시장 규모 : 제품별 - 이종 이식의 시장 규모 - 동종 이식의 시장 규모 - 인공 골이식의 시장 규모 - DBM의 시장 규모 ・세계의 골이식편 및 골대체물 시장 규모 : 용도별 - 척추 고정술에 사용되는 골이식편 및 골대체물의 시장 규모 - 외상에 사용되는 골이식편 및 골대체물의 시장 규모 - 두개골 안면에 사용되는 골이식편 및 골대체물의 시장 규모 - 관절 재건에 사용되는 골이식편 및 골대체물의 시장 규모 - 기타 용도에 사용되는 골이식편 및 골대체물의 시장 규모 ・고객 현황 ・지역별 현황 - 북미의 골이식편 및 골대체물 시장 규모 - 유럽의 골이식편 및 골대체물 시장 규모 - 아시아 태평양의 의 골이식편 및 골대체물 시장 규모 - 기타 지역의 골이식편 및 골대체물 시장 규모 - 미국의 골이식편 및 골대체물 시장 규모 - 독일의 골이식편 및 골대체물 시장 규모 - 영국의 골이식편 및 골대체물 시장 규모 - 중국의 골이식편 및 골대체물 시장 규모 - 일본의 골이식편 및 골대체물 시장 규모 ・성장 요인/과제/동향 ・기업 현황 ・기업 분석 Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 골이식편 및 골대체물 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 골이식편 및 골대체물 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
글로벌 뼈 이식 및 대체재 시장은 2023-2027년 동안 1450.51백만 달러 성장할 것으로 예상되며, 이 기간 동안 연평균 성장률(CAGR)은 8.71%에 이를 것으로 보입니다. 이 보고서는 뼈 이식 및 대체재 시장에 대한 포괄적인 분석, 시장 규모 및 예측, 트렌드, 성장 동력 및 도전 과제, 약 25개 공급업체를 포함한 공급업체 분석을 제공합니다. 현재 시장 상황, 최신 트렌드 및 동향, 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 시장 성장의 주요 원인은 증가하는 정형외과 질환 및 수술 건수, 치과용 뼈 이식에 대한 수요 증가, 임상 시험에 대한 투자 증가입니다.
이 연구는 뼈 이식 및 대체재 시장을 다음과 같이 세분화합니다: 제품별로는 외래 이식(xenografts), 동종 이식(allografts), 합성 뼈 이식(synthetic bone grafts), 그리고 DBM(demineralized bone matrix)으로 구분됩니다. 응용 분야에 따라 척추 융합(spinal fusion), 외상(trauma), 두개안면(craniomaxillofacial), 관절 재건(joint reconstruction), 치과 뼈 이식(dental bone grafting)으로 나뉩니다. 지역별로는 북미, 유럽, 아시아, 기타 지역(Rest of World, ROW)으로 구분됩니다.
이 연구는 최소 침습 수술의 증가하는 채택이 향후 몇 년 간 뼈 이식 및 대체재 시장 성장을 이끄는 주요 이유 중 하나라고 밝히고 있습니다. 또한, 뼈 이식에서의 3D 프린팅의 출현과 개발도상국에서의 치과 관광 증가도 시장에 상당한 수요를 창출할 것입니다.
Technavio는 여러 출처로부터 수집한 데이터를 종합하여 시장을 자세히 분석하며, 뼈 이식 및 대체재 시장의 크기, 예측, 산업 분석을 포함합니다. 이 보고서는 AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corp., Johnson and Johnson, Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc., OST Laboratories, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., TBF TISSUE ENGINEERING, Xtant Medical Inc., Zimmer Biomet Holdings Inc. 등 여러 주요 공급업체에 대한 자세한 분석을 제공합니다. 또한, 향후 시장 성장에 영향을 미칠 최신 트렌드와 도전 과제에 대한 정보도 포함되어 있어 기업들이 전략을 수립하고 앞으로의 성장 기회를 활용하는 데 도움을 줍니다.
이 연구는 산업 주요 참여자들로부터의 입력을 포함한 객관적인 1차 및 2차 정보를 조합하여 수행되었습니다. 보고서는 포괄적인 시장 및 공급업체 경관, 주요 공급업체 분석을 포함하며, 시장의 여러 측면을 식별하여 주요 산업 영향을 미치는 요소를 파악합니다. 제시된 데이터는 신뢰할 수 있고 포괄적이며, 광범위한 연구 결과입니다. Technavio의 시장 조사 보고서는 완전한 경쟁 경관과 심층적인 공급업체 선택 방법론 및 분석을 제공하여 정확한 시장 성장을 예측할 수 있는 정성적 및 정량적 연구를 기반으로 하고 있습니다.
■ 보고서 목차• 1 요약 • 3 시장 규모 • 4 과거 시장 규모 o 표 38: 동종이식 차트 – 2022-2027년 시장 규모 및 전망 (백만 달러) 표 56: 척추 유합술 시장 규모 및 전망 차트 2022-2027 (백만 달러) o 표 60: 외상 – 시장 규모 및 전망 차트 2022-2027 (백만 달러) o 표 64: 두개악안면외과 시장 차트 – 2022-2027년 (백만 달러) o 표 68: 관절 재건술 – 시장 규모 및 전망 2022-2027 차트 (백만 달러) o 표 72: 치아 골 이식술 – 시장 규모 및 전망 2022-2027 차트 (백만 달러) o 표 111: 중국 시장 규모 및 전망 2022-2027 차트 (백만 달러) o 표 115: 일본 – 2022-2027년 시장 규모 및 전망 차트(백만 달러) o 표 119: 지역별 시장 기회(백만 달러) o 표 124: 주요 위험이 사업에 미치는 영향 o 12.1 분석 대상 공급업체 o 표 187: 스트라이커(Stryker Corp.) – 주요 뉴스 첨부 자료: 표 1: 요약 – 시장 개요 차트 표 31: 제품별 시장 점유율 데이터 표 (2022-2027년, %) 표 32: 제품별 비교 차트 표 33: 제품별 비교 데이터 표 표 34: 이종이식 시장 규모 및 전망 차트 (2022-2027년, 백만 달러) 표 43: 합성 골 이식재 데이터 표 – 시장 규모 및 전망 2022-2027 (백만 달러) 첨부자료 51: 제품별 시장 기회 데이터 표 (백만 달러) 첨부자료 53: 적용 분야별 시장 점유율 데이터 표 (2022-2027년, %) 첨부자료 54: 적용 분야별 비교 차트 첨부자료 55: 적용 분야별 비교 데이터 표 첨부자료 56: S 차트 척추 유합술 – 시장 규모 및 전망 2022-2027 (백만 달러) 표 71: 관절 재건술 데이터 표 – 2022-2027년 전년 대비 성장률(%) 첨부자료 153: 존슨앤존슨 – 주요 뉴스 첨부자료 158: 메드트로닉 – 주요 뉴스 o 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market by Geography o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global bone grafts and substitutes market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on Global bone grafts and substitutes market 2017 - 2021 ($ million) o 4.2 Product Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million) o 4.3 Application Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Product o 6.1 Market segments o Exhibit 30: Chart on Product - Market share 2022-2027 (%) o Exhibit 31: Data Table on Product - Market share 2022-2027 (%) o 6.2 Comparison by Product o Exhibit 32: Chart on Comparison by Product o Exhibit 33: Data Table on Comparison by Product o 6.3 Xenografts - Market size and forecast 2022-2027 o Exhibit 34: Chart on Xenografts - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Xenografts - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Xenografts - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Xenografts - Year-over-year growth 2022-2027 (%) o 6.4 Allografts - Market size and forecast 2022-2027 o Exhibit 38: Chart on Allografts - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Allografts - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Allografts - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Allografts - Year-over-year growth 2022-2027 (%) o 6.5 Synthetic bone grafts - Market size and forecast 2022-2027 o Exhibit 42: Chart on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million) o Exhibit 43: Data Table on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million) o Exhibit 44: Chart on Synthetic bone grafts - Year-over-year growth 2022-2027 (%) o Exhibit 45: Data Table on Synthetic bone grafts - Year-over-year growth 2022-2027 (%) o 6.6 DBM - Market size and forecast 2022-2027 o Exhibit 46: Chart on DBM - Market size and forecast 2022-2027 ($ million) o Exhibit 47: Data Table on DBM - Market size and forecast 2022-2027 ($ million) o Exhibit 48: Chart on DBM - Year-over-year growth 2022-2027 (%) o Exhibit 49: Data Table on DBM - Year-over-year growth 2022-2027 (%) o 6.7 Market opportunity by Product o Exhibit 50: Market opportunity by Product ($ million) o Exhibit 51: Data Table on Market opportunity by Product ($ million) • 7 Market Segmentation by Application o 7.1 Market segments o Exhibit 52: Chart on Application - Market share 2022-2027 (%) o Exhibit 53: Data Table on Application - Market share 2022-2027 (%) o 7.2 Comparison by Application o Exhibit 54: Chart on Comparison by Application o Exhibit 55: Data Table on Comparison by Application o 7.3 Spinal fusion - Market size and forecast 2022-2027 o Exhibit 56: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million) o Exhibit 57: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million) o Exhibit 58: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%) o Exhibit 59: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%) o 7.4 Trauma - Market size and forecast 2022-2027 o Exhibit 60: Chart on Trauma - Market size and forecast 2022-2027 ($ million) o Exhibit 61: Data Table on Trauma - Market size and forecast 2022-2027 ($ million) o Exhibit 62: Chart on Trauma - Year-over-year growth 2022-2027 (%) o Exhibit 63: Data Table on Trauma - Year-over-year growth 2022-2027 (%) o 7.5 Craniomaxillofacial - Market size and forecast 2022-2027 o Exhibit 64: Chart on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million) o Exhibit 65: Data Table on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million) o Exhibit 66: Chart on Craniomaxillofacial - Year-over-year growth 2022-2027 (%) o Exhibit 67: Data Table on Craniomaxillofacial - Year-over-year growth 2022-2027 (%) o 7.6 Joint reconstruction - Market size and forecast 2022-2027 o Exhibit 68: Chart on Joint reconstruction - Market size and forecast 2022-2027 ($ million) o Exhibit 69: Data Table on Joint reconstruction - Market size and forecast 2022-2027 ($ million) o Exhibit 70: Chart on Joint reconstruction - Year-over-year growth 2022-2027 (%) o Exhibit 71: Data Table on Joint reconstruction - Year-over-year growth 2022-2027 (%) o 7.7 Dental bone grafting - Market size and forecast 2022-2027 o Exhibit 72: Chart on Dental bone grafting - Market size and forecast 2022-2027 ($ million) o Exhibit 73: Data Table on Dental bone grafting - Market size and forecast 2022-2027 ($ million) o Exhibit 74: Chart on Dental bone grafting - Year-over-year growth 2022-2027 (%) o Exhibit 75: Data Table on Dental bone grafting - Year-over-year growth 2022-2027 (%) o 7.8 Market opportunity by Application o Exhibit 76: Market opportunity by Application ($ million) o Exhibit 77: Data Table on Market opportunity by Application ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 79: Chart on Market share by geography 2022-2027 (%) o Exhibit 80: Data Table on Market share by geography 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 81: Chart on Geographic comparison o Exhibit 82: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 Asia - Market size and forecast 2022-2027 o Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 US - Market size and forecast 2022-2027 o Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.8 Germany - Market size and forecast 2022-2027 o Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.9 UK - Market size and forecast 2022-2027 o Exhibit 107: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 108: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 109: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 110: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.10 China - Market size and forecast 2022-2027 o Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million) o Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million) o Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%) o Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%) o 9.11 Japan - Market size and forecast 2022-2027 o Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity by geography o Exhibit 119: Market opportunity by geography ($ million) o Exhibit 120: Data Tables on Market opportunity by geography ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 121: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 123: Overview on factors of disruption o 11.4 Industry risks o Exhibit 124: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 125: Vendors covered o 12.2 Market positioning of vendors o Exhibit 126: Matrix on vendor position and classification o 12.3 AlloSource o Exhibit 127: AlloSource - Overview o Exhibit 128: AlloSource - Product / Service o Exhibit 129: AlloSource - Key offerings o 12.4 Arthrex Inc. o Exhibit 130: Arthrex Inc. - Overview o Exhibit 131: Arthrex Inc. - Product / Service o Exhibit 132: Arthrex Inc. - Key offerings o 12.5 Baxter International Inc. o Exhibit 133: Baxter International Inc. - Overview o Exhibit 134: Baxter International Inc. - Business segments o Exhibit 135: Baxter International Inc. - Key news o Exhibit 136: Baxter International Inc. - Key offerings o Exhibit 137: Baxter International Inc. - Segment focus o 12.6 Bioventus LLC o Exhibit 138: Bioventus LLC - Overview o Exhibit 139: Bioventus LLC - Business segments o Exhibit 140: Bioventus LLC - Key news o Exhibit 141: Bioventus LLC - Key offerings o Exhibit 142: Bioventus LLC - Segment focus o 12.7 Geistlich Pharma AG o Exhibit 143: Geistlich Pharma AG - Overview o Exhibit 144: Geistlich Pharma AG - Product / Service o Exhibit 145: Geistlich Pharma AG - Key offerings o 12.8 Integra Lifesciences Holdings Corp. o Exhibit 146: Integra Lifesciences Holdings Corp. - Overview o Exhibit 147: Integra Lifesciences Holdings Corp. - Business segments o Exhibit 148: Integra Lifesciences Holdings Corp. - Key news o Exhibit 149: Integra Lifesciences Holdings Corp. - Key offerings o Exhibit 150: Integra Lifesciences Holdings Corp. - Segment focus o 12.9 Johnson and Johnson o Exhibit 151: Johnson and Johnson - Overview o Exhibit 152: Johnson and Johnson - Business segments o Exhibit 153: Johnson and Johnson - Key news o Exhibit 154: Johnson and Johnson - Key offerings o Exhibit 155: Johnson and Johnson - Segment focus o 12.10 Medtronic Plc o Exhibit 156: Medtronic Plc - Overview o Exhibit 157: Medtronic Plc - Business segments o Exhibit 158: Medtronic Plc - Key news o Exhibit 159: Medtronic Plc - Key offerings o Exhibit 160: Medtronic Plc - Segment focus o 12.11 MTF Biologics o Exhibit 161: MTF Biologics - Overview o Exhibit 162: MTF Biologics - Product / Service o Exhibit 163: MTF Biologics - Key offerings o 12.12 NovaBone Products LLC o Exhibit 164: NovaBone Products LLC - Overview o Exhibit 165: NovaBone Products LLC - Product / Service o Exhibit 166: NovaBone Products LLC - Key offerings o 12.13 Nuvasive Inc. o Exhibit 167: Nuvasive Inc. - Overview o Exhibit 168: Nuvasive Inc. - Business segments o Exhibit 169: Nuvasive Inc. - Key news o Exhibit 170: Nuvasive Inc. - Key offerings o Exhibit 171: Nuvasive Inc. - Segment focus o 12.14 Orthofix Medical Inc. o Exhibit 172: Orthofix Medical Inc. - Overview o Exhibit 173: Orthofix Medical Inc. - Business segments o Exhibit 174: Orthofix Medical Inc. - Key news o Exhibit 175: Orthofix Medical Inc. - Key offerings o Exhibit 176: Orthofix Medical Inc. - Segment focus o 12.15 OST Laboratories o Exhibit 177: OST Laboratories - Overview o Exhibit 178: OST Laboratories - Product / Service o Exhibit 179: OST Laboratories - Key offerings o 12.16 Smith and Nephew plc o Exhibit 180: Smith and Nephew plc - Overview o Exhibit 181: Smith and Nephew plc - Business segments o Exhibit 182: Smith and Nephew plc - Key news o Exhibit 183: Smith and Nephew plc - Key offerings o Exhibit 184: Smith and Nephew plc - Segment focus o 12.17 Stryker Corp. o Exhibit 185: Stryker Corp. - Overview o Exhibit 186: Stryker Corp. - Business segments o Exhibit 187: Stryker Corp. - Key news o Exhibit 188: Stryker Corp. - Key offerings o Exhibit 189: Stryker Corp. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 190: Inclusions checklist o Exhibit 191: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 192: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 193: Research methodology o Exhibit 194: Validation techniques employed for market sizing o Exhibit 195: Information sources o 13.5 List of abbreviations o Exhibit 196: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by Application Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on Global bone grafts and substitutes market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Product - Market share 2022-2027 (%) Exhibits31: Data Table on Product - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Product Exhibits33: Data Table on Comparison by Product Exhibits34: Chart on Xenografts - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Xenografts - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Xenografts - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Xenografts - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Allografts - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Allografts - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Allografts - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Allografts - Year-over-year growth 2022-2027 (%) Exhibits42: Chart on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million) Exhibits43: Data Table on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million) Exhibits44: Chart on Synthetic bone grafts - Year-over-year growth 2022-2027 (%) Exhibits45: Data Table on Synthetic bone grafts - Year-over-year growth 2022-2027 (%) Exhibits46: Chart on DBM - Market size and forecast 2022-2027 ($ million) Exhibits47: Data Table on DBM - Market size and forecast 2022-2027 ($ million) Exhibits48: Chart on DBM - Year-over-year growth 2022-2027 (%) Exhibits49: Data Table on DBM - Year-over-year growth 2022-2027 (%) Exhibits50: Market opportunity by Product ($ million) Exhibits51: Data Table on Market opportunity by Product ($ million) Exhibits52: Chart on Application - Market share 2022-2027 (%) Exhibits53: Data Table on Application - Market share 2022-2027 (%) Exhibits54: Chart on Comparison by Application Exhibits55: Data Table on Comparison by Application Exhibits56: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million) Exhibits57: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million) Exhibits58: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%) Exhibits59: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%) Exhibits60: Chart on Trauma - Market size and forecast 2022-2027 ($ million) Exhibits61: Data Table on Trauma - Market size and forecast 2022-2027 ($ million) Exhibits62: Chart on Trauma - Year-over-year growth 2022-2027 (%) Exhibits63: Data Table on Trauma - Year-over-year growth 2022-2027 (%) Exhibits64: Chart on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million) Exhibits65: Data Table on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million) Exhibits66: Chart on Craniomaxillofacial - Year-over-year growth 2022-2027 (%) Exhibits67: Data Table on Craniomaxillofacial - Year-over-year growth 2022-2027 (%) Exhibits68: Chart on Joint reconstruction - Market size and forecast 2022-2027 ($ million) Exhibits69: Data Table on Joint reconstruction - Market size and forecast 2022-2027 ($ million) Exhibits70: Chart on Joint reconstruction - Year-over-year growth 2022-2027 (%) Exhibits71: Data Table on Joint reconstruction - Year-over-year growth 2022-2027 (%) Exhibits72: Chart on Dental bone grafting - Market size and forecast 2022-2027 ($ million) Exhibits73: Data Table on Dental bone grafting - Market size and forecast 2022-2027 ($ million) Exhibits74: Chart on Dental bone grafting - Year-over-year growth 2022-2027 (%) Exhibits75: Data Table on Dental bone grafting - Year-over-year growth 2022-2027 (%) Exhibits76: Market opportunity by Application ($ million) Exhibits77: Data Table on Market opportunity by Application ($ million) Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits79: Chart on Market share by geography 2022-2027 (%) Exhibits80: Data Table on Market share by geography 2022-2027 (%) Exhibits81: Chart on Geographic comparison Exhibits82: Data Table on Geographic comparison Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits92: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits93: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits107: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits108: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits109: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits110: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits111: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibits112: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibits113: Chart on China - Year-over-year growth 2022-2027 (%) Exhibits114: Data Table on China - Year-over-year growth 2022-2027 (%) Exhibits115: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits116: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits117: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits118: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits119: Market opportunity by geography ($ million) Exhibits120: Data Tables on Market opportunity by geography ($ million) Exhibits121: Impact of drivers and challenges in 2022 and 2027 Exhibits122: Overview on Criticality of inputs and Factors of differentiation Exhibits123: Overview on factors of disruption Exhibits124: Impact of key risks on business Exhibits125: Vendors covered Exhibits126: Matrix on vendor position and classification Exhibits127: AlloSource - Overview Exhibits128: AlloSource - Product / Service Exhibits129: AlloSource - Key offerings Exhibits130: Arthrex Inc. - Overview Exhibits131: Arthrex Inc. - Product / Service Exhibits132: Arthrex Inc. - Key offerings Exhibits133: Baxter International Inc. - Overview Exhibits134: Baxter International Inc. - Business segments Exhibits135: Baxter International Inc. - Key news Exhibits136: Baxter International Inc. - Key offerings Exhibits137: Baxter International Inc. - Segment focus Exhibits138: Bioventus LLC - Overview Exhibits139: Bioventus LLC - Business segments Exhibits140: Bioventus LLC - Key news Exhibits141: Bioventus LLC - Key offerings Exhibits142: Bioventus LLC - Segment focus Exhibits143: Geistlich Pharma AG - Overview Exhibits144: Geistlich Pharma AG - Product / Service Exhibits145: Geistlich Pharma AG - Key offerings Exhibits146: Integra Lifesciences Holdings Corp. - Overview Exhibits147: Integra Lifesciences Holdings Corp. - Business segments Exhibits148: Integra Lifesciences Holdings Corp. - Key news Exhibits149: Integra Lifesciences Holdings Corp. - Key offerings Exhibits150: Integra Lifesciences Holdings Corp. - Segment focus Exhibits151: Johnson and Johnson - Overview Exhibits152: Johnson and Johnson - Business segments Exhibits153: Johnson and Johnson - Key news Exhibits154: Johnson and Johnson - Key offerings Exhibits155: Johnson and Johnson - Segment focus Exhibits156: Medtronic Plc - Overview Exhibits157: Medtronic Plc - Business segments Exhibits158: Medtronic Plc - Key news Exhibits159: Medtronic Plc - Key offerings Exhibits160: Medtronic Plc - Segment focus Exhibits161: MTF Biologics - Overview Exhibits162: MTF Biologics - Product / Service Exhibits163: MTF Biologics - Key offerings Exhibits164: NovaBone Products LLC - Overview Exhibits165: NovaBone Products LLC - Product / Service Exhibits166: NovaBone Products LLC - Key offerings Exhibits167: Nuvasive Inc. - Overview Exhibits168: Nuvasive Inc. - Business segments Exhibits169: Nuvasive Inc. - Key news Exhibits170: Nuvasive Inc. - Key offerings Exhibits171: Nuvasive Inc. - Segment focus Exhibits172: Orthofix Medical Inc. - Overview Exhibits173: Orthofix Medical Inc. - Business segments Exhibits174: Orthofix Medical Inc. - Key news Exhibits175: Orthofix Medical Inc. - Key offerings Exhibits176: Orthofix Medical Inc. - Segment focus Exhibits177: OST Laboratories - Overview Exhibits178: OST Laboratories - Product / Service Exhibits179: OST Laboratories - Key offerings Exhibits180: Smith and Nephew plc - Overview Exhibits181: Smith and Nephew plc - Business segments Exhibits182: Smith and Nephew plc - Key news Exhibits183: Smith and Nephew plc - Key offerings Exhibits184: Smith and Nephew plc - Segment focus Exhibits185: Stryker Corp. - Overview Exhibits186: Stryker Corp. - Business segments Exhibits187: Stryker Corp. - Key news Exhibits188: Stryker Corp. - Key offerings Exhibits189: Stryker Corp. - Segment focus Exhibits190: Inclusions checklist Exhibits191: Exclusions checklist Exhibits192: Currency conversion rates for US$ Exhibits193: Research methodology Exhibits194: Validation techniques employed for market sizing Exhibits195: Information sources Exhibits196: List of abbreviations |
| ※참고 정보 골이식편 및 골대체물은 뼈의 결손이나 손상을 보완하거나 회복하기 위해 사용하는 생체 재료입니다. 이러한 재료들은 일반적으로 외상, 질병, 종양 제거 등의 결과로 발생한 뼈 결손을 치유하는 데 중요한 역할을 합니다. 골이식편은 주로 조직의 재생을 촉진하고, 형태적 안정성을 제공하며, 영구적인 구조를 형성하도록 돕습니다. 골이식편은 크게 자가이식편, 동종이식편, 이종이식편, 합성골이식편으로 나눌 수 있습니다. 자가이식편은 환자의 다른 부위에서 채취한 뼈로, 가장 높은 생체적합성을 제공합니다. 동종이식편은 인간 기증자로부터 얻은 뼈로, 주로 뼈 뱅크에서 처리되어 사용됩니다. 이종이식편은 다른 종, 예를 들어 소나 돼지에서 채취한 뼈로, 세포 제거 및 멸균 과정을 거쳐 사용됩니다. 마지막으로 합성골이식편은 인공적으로 만들어진 재료로, 생체재료 과학의 발전으로 인해 다양한 형태와 성질을 갖추고 있습니다. 골대체물은 자연적인 뼈 대신에 사용할 수 있는 합성 재료로, 일반적으로 인체에 안전하며 생체적합성을 갖추어야 합니다. 재료로는 칼슘 인산염, 하이드록시아파타이트, 폴리머, 생체 활성 유리 등이 있습니다. 이들은 뼈의 재생을 촉진하고, 기계적인 강도를 제공하는 데 도움을 줍니다. 이러한 대체물은 뼈 형성이 필요한 임상 상황에서 점점 더 많이 사용되고 있습니다. 골이식편과 골대체물의 주된 용도는 뼈 결손의 치료입니다. 이들은 치과, 정형외과, 신경외과 등 다양한 분야에서 사용되며, 특히 치과 임플란트, 골절 치유, 관절 대체 수술 등에서 중요한 역할을 합니다. 예를 들어, 치과 임플란트 수술에서는 뼈의 밀도가 부족한 환자를 위해 자가이식편이나 합성골대체물이 사용되어 임플란트의 안정성을 높입니다. 최근에는 재생의학 기술과 생체재료의 발전으로 골이식편 및 대체물의 연구가 활발하게 이루어지고 있습니다. 재생의학의 한 분야인 줄기세포 치료는 뼈 재생을 위한 새로운 접근 방식으로 주목받고 있으며, 골이식의 효과를 극대화하는 데 기여하고 있습니다. 또한, 나노기술을 적용하여 생체재료의 물리적, 화학적 특성을 제어하는 연구도 진행되고 있습니다. 이러한 기술들은 향후 골이식편과 대체물의 효율성을 향상시킬 것으로 기대됩니다. 전반적으로 골이식편 및 골대체물은 뼈 재생의 중요한 도구로, 다양한 임상 상황에서 활용되고 있으며, 앞으로도 기술의 발전과 함께 그 사용 범위와 효과성이 더욱 확대될 것입니다. |
| ※본 조사보고서 [세계의 골이식편 및 골대체물 시장 (2023년~2027년)] (코드 : IRTNTR73350-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 골이식편 및 골대체물 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |

